Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle
Recommended Citation
Gamage NH, Jing L, Worsham MJ, and Ali MM. Targeted theranostic approach for glioma using dendrimer-based curcumin nanoparticle. J Nanomed Nanotechnol 2016; 7(4).
Document Type
Article
Publication Date
8-1-2016
Publication Title
J Nanomed Nanotechnol
Abstract
The delivery of anti-cancer agents to brain tumors represent a challenge because the blood-brain tumor barrier (BBTB) effectively limits the delivery of many agents. A new generation 3 (G3) dendrimer-based curcumin (Curc) conjugate was synthesized. The synthesized G3-Curc conjugate demonstrated full solubility in aqueous media. The in vitro study revealed that G3-Curc nanoparticles were internalized into glioma U-251 cells. Systemic delivery of G3-Curc conjugate led to preferentially accumulation in an orthotopic preclinical glioma model minimizing systemic toxic effect. Multicolor microscopy images of the tumor tissue showed that G3-Curc particles were internalized inside tumor cells selectively and further localized within nuclei. Enhanced bioavailability of G3-Curc conjugate was also observed with improved therapeutic efficacy against different cancers cells.
PubMed ID
27699139
Volume
7
Issue
4
